Blanchard Conombo

Blanchard Conombo

Auto-generated profile, based on publicly available information

Blanchard Conombo

International Agency for Research on Cancer, Lyon, France

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2022 in International Journal of Technology Assessment in Health Care
Verified
Journal Article
Open access
PDF file
Thomas G. PoderThomas G. Poder
Thomas G. Poder
LCLucien P. Coulibaly
Lucien P. Coulibaly
AHAbakar Idriss Hassan
Abakar Idriss Hassan
BCBlanchard Conombo
Blanchard Conombo
Maude LabergeMaude Laberge
Maude Laberge
Objectives: To investigate the test–retest reliability of the Costs for Patients Questionnaire (CoPaQ).Methods: Through an online survey, individuals were invited to participate in a two-step study to assess the test–retest reliability of the CoPaQ. Participants to the first step were invited to complete the questionnaire a second time 2 weeks after. Reliability was assessed by calculating Cohen’s Kappa coefficients and intraclass correlation coefficients (ICC) for discrete and continuous data, respectively. A sensitivity analysis was carried out.Results: From a total of 1,200 participants who completed the first test, 403 completed the second test. The ICC varied from −0.00 to 0.98 with poor, moderate, good, and excellent results. The Kappa coefficients varied from −0.004 to 0.65 and were poor, slight, fair, moderate, and substantial. The sensitivity analysis showed the median value of ICC and Kappa coefficients for each category before and after the outliers’ exclusion. The median value of ICC changed from 0.30 (before) to 0.70 (after), and from 0.12 (before) to 0.04 (after), respectively, for each category. The median value of the Cohen’s Kappa coefficient increased from 0.44 (before) to 0.46 (after) and decreased from 0.32 (before) to 0.30 (after), respectively.Conclusions: Test–retest reliability results indicated that the CoPaQ has a moderate reliability in terms of ICC and Kappa coefficients. The moderate reliability observed gives additional support for the applicability of this tool in economic evaluations of health interventions. Additional studies including on other properties and a cultural adaptation could further enhance the use of the tool.

5 July 2020 in Medical Decision Making
Verified
Journal Article
Closed access
PDF file
JGJason Robert GUERTIN
Jason Robert GUERTIN
BCBlanchard Conombo
Blanchard Conombo
RLRaphaël Langevin
Raphaël Langevin
FBFrederic Bergeron
Frederic Bergeron
AHAnne Holbrook
Anne Holbrook
MDMadeleine Durand
Madeleine Durand
Background. Observational economic evaluations (i.e., economic evaluations in which treatment allocation is not randomized) are prone to confounding bias. Prior reviews published in 2013 have shown that adjusting for confounding is poorly done, if done at all. Although these reviews raised awareness on the issues, it is unclear if their results improved the methodological quality of future work. We therefore aimed to investigate whether and how confounding was accounted for in recently published observational economic evaluations in the field of cardiology. Methods. We performed a systematic review of PubMed, Embase, Cochrane Library, Web of Science, and PsycInfo databases using a set of Medical Subject Headings and keywords covering topics in “observational economic evaluations in health within humans” and “cardiovascular diseases.” Any study published in either English or French between January 1, 2013, and December 31, 2017, addressing our search criteria was eligible for inclusion in our review. Our protocol was registered with PROSPERO (CRD42018112391). Results. Forty-two (0.6%) out of 7523 unique citations met our inclusion criteria. Fewer than half of the selected studies adjusted for confounding (n = 19 [45.2%]). Of those that adjusted for confounding, propensity score matching (n = 8 [42.1%]) and other matching-based approaches were favored (n = 8 [42.1%]). Our results also highlighted that most authors who adjusted for confounding rarely justified their methodological choices. Conclusion. Our results indicate that adjustment for confounding is often ignored when conducting an observational economic evaluation. Continued knowledge translation efforts aimed at improving researchers’ knowledge regarding confounding bias and methods aimed at addressing this issue are required and should be supported by journal editors.

14 July 2020 in BMJ Open
Verified
Journal Article
Open access
PDF file
BCBlanchard Conombo
Blanchard Conombo
JGJason Robert GUERTIN
Jason Robert GUERTIN
PTPier-Alexandre Tardif
Pier-Alexandre Tardif
IFImen Farhat
Imen Farhat
TMThomas Moore
Thomas Moore
LMLynne Moore
Lynne Moore
Introduction Underuse of high-value clinical practices and overuse of low-value practices are major sources of inefficiencies in modern healthcare systems. Injuries are second only to cardiovascular disease in terms of acute care costs but data on the economic impact of clinical practices for injury admissions are lacking. This study aims to summarise evidence on the economic value of intrahospital clinical practices for injury care. Methods and analysis We will perform a systematic review to identify research articles in economic evaluation of intrahospital clinical practices in acute injury care. We will search MEDLINE and databases such as Embase, Web of Science, NHS Economic Evaluation Database, Cochrane CENTRAL, BIOSIS and CINAHL for randomised or non-randomised controlled trials and observational studies using a combination of keywords and controlled vocabulary. We will consider the following outcomes relative to economic evaluations: incremental cost-effectiveness ratio, incremental cost-utility ratio, incremental net health benefit, incremental net monetary benefit (iNMB) and incremental cost-benefit ratio. Pairs of independent reviewers will evaluate studies that meet eligibility criteria and extract data from included articles using an electronic data extraction form. All outcomes will be converted into iNMB. We will report iNMB for practices classified by type of practice (hospitalisation, consultation, diagnostic, therapeutic-surgical, therapeutic-drugs, therapeutic-other). Results obtained with a ceiling ratio of $50 000 per quality-adjusted life year gained for identified clinical practices will be summarised by charting forest plots. In line with Cochrane recommendations for systematic reviews of economic evaluations, meta-analyses will not be conducted. Ethics and dissemination Ethics approval is not required as original data will not be collected. This study will summarise existing evidence on the economic value of clinical practices in injury care. Results will be used to advance knowledge on value-based care for injury admissions and will be disseminated through a peer-reviewed article, international scientific meetings and clinical and healthcare quality associations.

15 June 2026 in BMJ Quality & Safety
Verified
Journal Article
Closed access
CHComlan Lucien Hountongbé
Comlan Lucien Hountongbé
JGJason Robert Guertin
Jason Robert Guertin
SGSoualio Gnanou
Soualio Gnanou
BCBlanchard Conombo
Blanchard Conombo
PTPier-Alexandre Tardif
Pier-Alexandre Tardif
LMLynne Moore
Lynne Moore
Background: Low-value practices, defined as tests or treatments that are used in practice despite not being supported by evidence, account for 20%–30% of healthcare expenditure; moreover, some identified low-value practices represent 16%–26% of primary care clinical services. Given the growing financial constraints healthcare systems face, evaluating the cost-effectiveness of interventions designed to reduce these practices is becoming urgent. Objective: We aimed to synthesise data on the economic value of deimplementation interventions. Methods: We evaluated the cost-effectiveness of interventions targeting the deimplementation of low-value practices among healthcare professionals and organisations (clinicians, hospitals and medical centres). Our comparator was either no intervention or a deimplementation intervention limited to a subset of the intervention components. Outcomes were incremental cost-effectiveness ratios, incremental cost-utility ratios and benefit-to-cost ratios. Studies where the intervention was dominant or dominated by the comparator were also considered. We developed search strategies for Cochrane, EMBASE, MEDLINE, CINAHL and Web of Science to February 2025. Pairs of independent reviewers sequentially screened titles, abstracts and full texts for eligibility and extracted data using a prepiloted extraction sheet. Methodological quality was assessed by two reviewers using the 19-item Consensus on Health Economic Criteria (CHEC), and results were synthesised visually using permutation matrices globally and for predefined subgroups. Results: Of the 35 575 unique records identified, 19 met our eligibility criteria. Deimplementation interventions were found to be dominant (ie, effective with lower cost) in 10 evaluations (53%), potentially favourable (more effective with higher cost) in 8 (42%) and unfavourable in 1 (5%). Deimplementation interventions were more likely to be economically favourable in studies accounting for both medical and intervention costs, those targeting healthcare professionals and those with high methodological quality. Conclusion: Our findings suggest that deimplementation interventions targeting low-value practices are highly likely to be cost-effective. However, the results should be interpreted with caution due to the low methodological quality of the studies and the lack of consideration of the societal perspective.